\
&
Contact us
\
&
Contact us
This was 1 month ago
LocationEuropean Parliament
Member of the European Parliament (MEP) Eszter Lakos and the European University Association (EUA) in collaboration with Universities UK International (UUKI) are organising an event on 'Harnessing international collaboration in research and innovation for competitiveness: How can the EU and its partners maximise value through Horizon Europe and the European Competitiveness Fund?’.
The event will explore how international collaboration contributes to European competitiveness and what policy conditions are needed to ensure that FP10 and the ECF deliver mutual benefits for the EU and its global partners.
More information such as the programme can be found on the event webpage.
You can register here until 9 January 2026.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
